Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model ; volume:20 ; number:1 ; day:14 ; month:12 ; year:2024 ; pages:1-16 ; date:12.2025
Journal of neuroImmune pharmacology ; 20, Heft 1 (14.12.2024), 1-16, 12.2025
- Creator
-
Garcia-Gomara, M.
Juan-Palencia, A.
Alfaro, M.
Cuadrado-Tejedor, M.
Garcia-Osta, A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11481-024-10164-4
- URN
-
urn:nbn:de:101:1-2502262103519.755368546940
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garcia-Gomara, M.
- Juan-Palencia, A.
- Alfaro, M.
- Cuadrado-Tejedor, M.
- Garcia-Osta, A.
- SpringerLink (Online service)
Other Objects (12)
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced habit-driven errors in Parkinson’s Disease
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease